• Skip to content
  • Accessibility help
Skip to content
Sign in
  • Guidance
  • Skip Standards and indicators submenu

    Quality standards

    Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.

    View our quality standards

    • How to use our quality standards
    • The timeline for developing quality standards
    • Help us develop quality standards
    • Selecting and prioritising quality standards topics
    • About quality standards

    Indicators

    Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.

    View list of indicators

    • Learn about the committee that develops indicators
    • About indicators
  • Skip Life sciences submenu

    Life Sciences

    We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.

    View life sciences

    Get support from NICE

    NICE Advice service

    Trusted, unrivalled expertise.

    Make an enquiry

    Contact us to discuss your requirements.

    Innovative Licensing and Access Pathway (ILAP)

    Streamlining patient access to safe, financially sustainable and innovative medicines.

    Learn how we evaluate technologies

    Health technology evaluation and topic selection manuals

    Updated manuals for methods, processes and topic selection.

    Digital health technologies

    Accelerating our efforts to deliver innovation to the health and care system.

    Evidence standards framework

    Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.

    Our guidance programmes

    Ensuring new technologies are clinically effective and offer economic value.

    Register your product

    Non-pharmaceutical

    NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.

    Pharmaceutical

    UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.

    Find published and proposed evaluations

    Diagnostics

    Guidance on measurements and tests used to evaluate a patient's condition.

    Medical technologies

    Guidance on medical technologies put forward to NICE by manufacturers.

    Technology appraisals

    Guidance on new and existing medicines and treatments in the NHS.

    Highly specialised technologies

    Guidance on the use of highly specialised medicines and treatments.

  • British National Formulary (BNF)
  • British National Formulary for Children (BNFC)
  • Clinical Knowledge Summaries (CKS)
  • Skip About submenu

    About

    NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.

    Explore about

    Our programmes

    Learn about the information we produce.

    • Guidance
    • Advice
    • Quality standards
    • Indicators
    • Digital health
    • Topic selection

    Get involved

    • Understand how decisions are made:

      Attend a committee meeting
    • Comment on draft guidance:

      Guidance in consultation
    • Be part of a guidance committee:

      Join a committee
    • Help develop our products:

      Register as a stakeholder
    • Putting you at the heart of our work:

      Public involvement

    What we do

    • Social care
    • Life sciences
    • NICE international
    • Patient safety
    • Shared decision making
    • View all What we do

    Into practice

    • Social care quick guides
    • Measuring the use of NICE guidance
    • Resource planner
    • View all Into practice

    Who we are

    • The board
    • The NICE strategy 2021 to 2026
    • Corporate publications
    • View all Who we are

    • Contact us
    • Jobs

My account

  • Consultation responses
  • Sign in

You are here:

  1. Home
  2. NICE Guidance
  3. Lifestyle and wellbeing
  4. Alcohol

Alcohol: preventing harmful use in the community

  • Quality standard
  • Reference number: QS83
  • Published:  25 March 2015
  • Quality standard
  • Tools and resources
  • History
Download (PDF)
  • Overview
  • Quality statements
  • Quality statement 1: Using local crime and related trauma data
  • Quality statement 2: Under-age sales
  • Quality statement 3: Alcohol education
  • Quality statement 4: Schools and colleges involve parents, carers, children and young people
  • Update information
  • About this quality standard

On this page

  1. Quality statement
  2. Rationale
  3. Quality measures
  4. What the quality statement means for different audiences
  5. Source guidance
  6. Definitions of terms used in this quality statement

Quality statement 1: Using local crime and related trauma data

Quality statement

Local authorities use local crime and related trauma data to map the extent of alcohol‑related problems, to inform the development or review of a statement of licensing policy.

Rationale

Using local data to identify problems caused by the sale of alcohol in an area enables the development of an evidence‑based, high‑quality policy on responsible licensing that will help to meet the licensing objectives.

Quality measures

The following measures can be used to assess the quality of care or service provision specified in the statement. They are examples of how the statement can be measured, and can be adapted and used flexibly.

Structure

Evidence that local crime and related trauma data are used to map the extent of alcohol‑related problems to inform the development or review of a statement of licensing policy.

Data source: Local data collection.

What the quality statement means for different audiences

Local authorities (through the licensing lead, public health team and trading standards) work in partnership with local health and crime agencies and other responsible authorities to ensure that there are arrangements for sharing local crime and related trauma data. These data should be used to map the extent of alcohol‑related problems in an area, to inform the development or review of a statement of licensing policy.

People in the community can be confident that information about crime and other alcohol‑related problems is taken into account by local authorities when they make decisions about licensing for alcohol. This should help to make areas safer and reduce problems related to alcohol, such as crime, health problems and accidents.

Source guidance

Alcohol-use disorders: prevention. NICE guideline PH24 (2010), recommendation 4

Definitions of terms used in this quality statement

Local crime and related trauma data

Data such as non‑personal details from hospital emergency departments about violent incidents (time, day, date, location, type of assault and whether weapons were used), ambulance data and crime data that can be mapped alongside locations of licensed premises. [Adapted from the Home Office alcohol strategy, section 3.22 and expert opinion]

Alcohol-related problems

Problems resulting from alcohol that may be indicated (perhaps by proxy) by local crime and related trauma data, such as crime and disorder, social issues and health harms. These include drunkenness and rowdy behaviour, assault, accidents and injuries, absence from work, financial costs, children growing up in families in which there is parental alcohol misuse, chronic health problems (mental and physical) and, in extreme circumstances, death. [Expert opinion]

Development or review of a statement of licensing policy

Every licensing authority is required to develop and publish a statement of its licensing policy and review it at least every 5 years. The statement of licensing policy explains the approach to licensing within the area and gives guidance to licence holders, applicants and any person who may have an interest in licence applications or review of licences. The statement of licensing policy might include a 'cumulative impact' policy. Cumulative impact policies allow licensing authorities to take into account whether a significant number of licensed premises are concentrated in 1 area and whether the evidence suggests that the licensing of more premises may affect the statutory licensing objectives and contribute to an increase in alcohol‑related disorder. Individual licence applications can be refused unless the applicant can demonstrate in their operating schedule that there will be no negative cumulative impact on 1 or more of the licensing objectives. Currently (March 2015) the 4 statutory licensing objectives are: the prevention of crime and disorder, public safety, the prevention of public nuisance and the protection of children from harm. [Adapted from NICE's guideline on alcohol-use disorders: prevention and the Home Office's revised guidance issued under section 182 of the Licensing Act 2003]


Next page Quality statement 2: Under-age sales Previous page Quality statements
Back to top
  • Guidance
  • Standards and indicators
  • Life sciences
  • British National Formulary (BNF)
  • British National Formulary for Children (BNFC)
  • Clinical Knowledge Summaries (CKS)
  • Knowledge resources
  • About NICE
  • Into practice
  • Get involved with NICE
  • Jobs
  • News
  • Newsletters and alerts
  • Contact us
  • Leave feedback
  • Reusing our content
  • NICE UK Open Content Licence
  • Syndicate our content
  • Events
  • Facebook
  • X
  • YouTube
  • LinkedIn
  • Accessibility
  • Freedom of information
  • Glossary
  • Terms and conditions
  • Privacy notice
  • Cookies

© NICE 2025. All rights reserved. Subject to Notice of rights.